Clinical Trial Update: Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether adalimumab alters immune responses to influenza and pneumococcal vaccines in rheumatoid arthritis; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED